SBC在基因检测行业中的票数：284
【SBC是哪个国家的品牌？】
外推网助力SBC品牌出海！将品牌入驻外推网，定制SBC品牌推广信息，可以显著提高SBC产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~
上海生物芯片有限公司成立于2001年8月，公司现有股东：上海科技创业投资（集团）有限公司、上海张江（集团）有限公司、中科院上海生命科学研究院、中科院上海微系统与信息技术研究所、复旦大学、上海交通大学、上海交通大学医学院附属瑞金医院和上海博星基因芯片有限公司。2003年2月，国家发展与改革委员会批准上海生物芯片有限公司建设和运行“生物芯片上海国家工程研究中心”项目并正式命名，项目总投资2.9亿元人民币。公司（中心）位于上海浦东张江高科技园区生物医药产业基地，总占地4万平方米，建筑面积2万多平方米，现有员工300余人。
根据国家发展与改革委员会对“生物芯片上海国家工程研究中心”项目的建设任务要求和公司发展战略，公司化国家工程研究中心专注于生物芯片在生命科学研究、医疗保健和药物开发等领域的应用和推广，通过十余年的建设和发展，确立了以生物样品组织库、组织芯片、基因表达谱芯片和测序等为核心平台的技术创新服务体系，以分子医学诊断技术和产品研发生产为核心竞争力的产业化体系，形成科研和药物研发技术服务、分子医学检验服务、和分子诊断产品研发生产销售等三大主营业务。公司（中心）已经步入了科研与合作、产品研发生产销售和技术服务以及开展国际合作和人才交流培养等良性发展轨道，具备了自主创新、市场竞争、和为行业服务贡献的能力。
公司（中心）本着“科研创新、市场导向、以人为本”的价值理念，按照国家工程研究中心的建设目标要求，努力使公司形成集技术创新、成果转化、综合服务、人才培养于一体，具有国际水平的国家生物芯片产业化基地；把公司建设成为具有国际水平和自主研发能力的行业标杆性科技创新型企业，为上海加快成为具有全球影响力的科技创新中心目标，为我国生物医药领域科技创新和产业化做出贡献。
英文翻译：Shanghai Biochip Co., Ltd. was founded in August 2001. The company's existing shareholders are: Shanghai Science and technology venture capital (Group) Co., Ltd., Shanghai Zhangjiang (Group) Co., Ltd., Shanghai Institute of life sciences, Chinese Academy of Sciences, Shanghai Institute of Microsystem and information technology, Fudan University, Shanghai Jiaotong University, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of medicine and Shanghai Bojin hospital Star gene chip Co., Ltd. In February 2003, the national development and Reform Commission approved Shanghai Biochip Co., Ltd. to build and operate the "biochip Shanghai National Engineering Research Center" project, which was officially named, with a total investment of 290 million yuan. The company (Center) is located in the biomedical industry base of Zhangjiang High Tech Park, Pudong, Shanghai, covering a total area of 40000 square meters, with a construction area of more than 20000 square meters and more than 300 employees. According to the requirements of the national development and Reform Commission for the construction of the "biochip Shanghai National Engineering Research Center" project and the company's development strategy, the company's National Engineering Research Center focuses on the application and promotion of biochip in the fields of life science research, medical care and drug development. Through more than ten years of construction and development, it has established a biological sample Organization database and group The technology innovation service system with weaving chip, gene expression profile chip and sequencing as the core platform, and the industrialization system with molecular medicine diagnosis technology and product R & D and production as the core competitiveness, formed three main businesses, including scientific research and drug R & D technology service, molecular medicine inspection service, and molecular diagnosis product R & D, production and sales. The company (Center) has stepped into the track of sound development, such as scientific research and cooperation, product R & D, production, sales and technical services, international cooperation and talent exchange and training, and has the ability of independent innovation, market competition and contribution to industry services. The company (Center) adheres to the value concept of "scientific research innovation, market-oriented and people-oriented" and in accordance with the construction objectives of the National Engineering Research Center, strives to form a national biochip industrialization base with international level integrating technological innovation, achievement transformation, comprehensive service and personnel training, and to build the company into an international level and independent R & D base The industry benchmarking technology innovation enterprises with capabilities contribute to Shanghai's goal of becoming a technology innovation center with global influence and to the technology innovation and industrialization of China's biomedical field.
本文链接： https://www.waitui.com/brand/f94539e02.html 联系电话：请联系客服添加 联系邮箱：请联系客服添加
浙公网安备 33011802001999号
